Loading
IARC estimates 10,722 new cancer cases and 6,509 cancer deaths in Honduras in 2024; the commonest new cancers are breast, prostate and leukaemia. This page is assembled automatically from OnCo's data, and says what OnCo does not yet hold.
| Site | New cases | Rate | OnCo page |
|---|---|---|---|
| Breast | 1,214 | 27.0 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Prostate | 852 | 27.3 | Prostate cancer |
| Leukaemia | 848 | 8.5 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Cervix uteri | 826 | 17.6 | Cervical cancer |
| Thyroid | 773 | 8.0 | Thyroid cancer |
| Stomach | 754 | 9.9 | Gastric & gastro-oesophageal junction cancer |
| Trachea, bronchus and lung | 556 | 7.5 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Colorectum | 507 | 6.5 | Colorectal cancer |
| Brain, central nervous system | 498 | 5.2 | Glioma & glioblastoma |
| Non-Hodgkin lymphoma | 437 | 5.0 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Site | Deaths | Rate | OnCo page |
|---|---|---|---|
| Stomach | 616 | 8.4 | Gastric & gastro-oesophageal junction cancer |
| Breast | 560 | 12.8 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Leukaemia | 542 | 5.6 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Trachea, bronchus and lung | 526 | 7.1 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Prostate | 521 | 16.8 | Prostate cancer |
| Cervix uteri | 495 | 10.6 | Cervical cancer |
| Brain, central nervous system | 403 | 4.3 | Glioma & glioblastoma |
| Liver and intrahepatic bile ducts | 331 | 4.3 | Hepatocellular carcinoma |
| Colorectum | 283 | 3.8 | Colorectal cancer |
| Pancreas | 233 | 3.2 | Pancreatic ductal adenocarcinoma |
No trial record in OnCo lists a site in Honduras. OnCo reads sites from ClinicalTrials.gov; studies registered only elsewhere are searchable through the WHO International Clinical Trials Registry Platform.
OnCo holds no institution, company or person in Honduras.
OnCo records approvals for United States, European Union, United Kingdom, Japan, China, Australia and India. Honduras is not one of them, so no approval in OnCo speaks for it. See the approvals by region matrix for what is held.
Honduras is not among the 60 countries ranked in the country coverage queue (November 2026), which ranks countries without a page by cases, deaths, research output and population. Know a source? Suggest an edit.